Estimated return — disclosed long book

What Patient Capital Management LLC’s US-listed long positions did, derived from the share counts and market values in consecutive 13F filings, shown against SPY over exactly the same quarters. This is not the fund’s return. A 13F excludes shorts, bonds, cash, non-US listings and derivatives, says nothing about fees or leverage, and only sees positions held at both quarter ends. The fund figure is a price return while SPY is a total return, so the comparison is tilted against the manager by roughly a dividend yield.

Q2 2026
+12.8%
SPY +15.1% -2.4%
2026 YTD(2Q so far)
+7.1%
SPY +10.1% -3.0%
By calendar year
YearEstimatedSPYDifference
2025+19.8%+17.7%+2.1%
2024+17.9%+24.9%-7.0%
2023+36.4%+26.2%+10.2%
2022-31.0%-18.2%-12.8%